Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial ; day:26 ; month:7 ; year:2016 ; pages:1-11
Graefe's archive for clinical and experimental ophthalmology ; (26.7.2016), 1-11
- Beteiligte Personen und Organisationen
-
Eter, Nicole
Mohr, Andreas
Wachtlin, Joachim
Feltgen, Nicolas
Shirlaw, Andrew
Leaback, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s00417-016-3431-x
- URN
-
urn:nbn:de:1111-201607283213
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eter, Nicole
- Mohr, Andreas
- Wachtlin, Joachim
- Feltgen, Nicolas
- Shirlaw, Andrew
- Leaback, Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion